entry inhibitors antiviral drug examples

entry inhibitors antiviral drug examples

Other potential sites for the design of flaviviral entry inhibitors. Because this viral entry is one of the key early steps in the viral life cycle , entry inhibitors have been successfully developed for antiviral therapies. A 15 y/o patient came in for a severe case of respiratory flu and would need drug therapy. There are some examples with pan-active flavivirus entry, protease, MTase, and RdRp (nucleoside) inhibitors. Target identification through biolayer interferometry confirmed binding of all hit compounds to HA. In this section, the COVID-19 Treatment Guidelines Panel (the Panel) provides recommendations for using antiviral drugs to treat COVID-19 based on the available data. It’s a first antiretroviral drug used in HIV infection. Antiviral Drugs. We use proprietary molecular descriptors and a huge amount of data and knowledge from literature to find relationships between molecular structures and biological activity. Our expert systems are based on novel models and innovative methods in the field of drug design. These are effective against rhinovirus (common cold), enteroviruses … The identification and validation of trichostatin A as a potent anti-SARS-CoV-2 drug compound has demonstrated the capability of our structure-based screening platform and in vitro enzyme inhibition and antiviral assays to discover SARS-CoV-2 M pro inhibitors from a large chemical library. Natella Y. Rakhmanina, Charles J.L. Nucleoside reverse transcriptase inhibitors (NRTIs) are active inhibitors of reverse transcriptase found in retroviruses such as the human immunodeficiency virus ().The different nucleoside reverse transcriptase inhibitors may be activated differently but they have the same mechanism of action. While the COVID-19 pandemic has spurred intense research and collaborative discovery worldwide, the development of a safe, effective, and targeted antiviral from the ground up is time intensive. Docked energies of the ligands bound to the 30 inhibited entry of SARS and SARS-2 pvs but not MERSpv. Covering: up to April 2014. The search for a suitable vaccine as well as effective therapeutics for the treatment of COVID-19 is underway. Next, we showed the antiviral properties of known enveloped virus entry inhibitors, 33 Spirulina and Green tea extracts against CoVpvs. To be effective, antiviral agents must either block viral entry into or exit from the cell or be active inside the host cell. disputed the mechanism of action proposed for BMS-378806 by Lin et al., assuming that BMS-378806 and related HIV-1 entry inhibitors bind … WNV. Examples of classes of kinase inhibitors with broad-spectrum antiviral activity and the specific steps of the viral life cycle they target (if known) are denoted in colored boxes. Recent advancement in computational biology made virtual screening of natural bioactive compounds, i.e., phytochemicals, a gold standard technique in current drug discovery pipelines (Kitchen et al. HIV. Antiviral Drugs Mode of Action •Entry Inhibitors –New group of drugs prevent viral entry into host cell •Enfuvirtide binds to an HIV protein that promotes fusion of viral envelope with cell membrane •Maraviroc blocks HIV co-receptor CCR5 •Viral Uncoating –Nucleic acid must separate from protein coat Examples of antiviral drugs include agents to combat herpes viruses, influenza viruses, and HIV. Three general antiviral strategies are generally found (13): 1) direct antiviral effects, 2) inhi-bition of viral entry and replication at the cellular level by targeting virus-related processes, and 3) enhancement of host immune response. They may cause significant neuropsychiatric complications, which range from mild symptoms such as irritability and difficulty sleeping to severe complications … Coronavirus disease 2019 (COVID-19) is a novel disease caused by the severe acute respiratory syndrome coronavirus (SARS-CoV)-2 virus that was first detected in December of 2019 in Wuhan, China, and has rapidly spread worldwide. In 2004, Si et al. - Entry inhibitors: target viral fusion (T20) and a host cell co-receptor (maraviroc) - Viral uncoating: amantadine/rimantadine - Nucleoside analogue chain termination e.g. Therapeutic Action. Despite the initial limited commercial suc-cess of zanamivir, the CADD strategies employed in its development were important first steps in the develop-ment of further sialidase inhibitors. The mechanism of hydroxycarbamide is thought to be based on the reduction of production of deoxyribonucleotides; therefore, inhibiting DNA synthesis. Examples of this new class of drugs include entry inhibitors, coreceptor antagonists, and fusion inhibitors. Please visit our nursing test bank page for more NCLEX practice questions. Prodrug -- must be activated Protease Inhibitors Description. Antiviral activity extends to an isolate from the 2009 pandemic and, in one case, another group 1 subtype. There are numerous examples of successful drug development targeting cellular and viral proteases, including antivirals against human immunodeficiency virus and hepatitis C virus. The nervous system is often affected and to date, many studies have been published regarding the central nervous system toxicity of antiviral agents. IV. Viral entry is a promising target for antiviral therapy. People whose virus has become resistant to current treatment, and those who face this predicament, are growing daily. Antiviral drug resistance is a matter of great clinical importance that, historically, has been investigated mostly from a virological perspective. A drug-screening assay that scores for virus-induced cytopathic effects on cultured cells was used. Development of novel antiviral molecules from the beginning costs an average of $350 million to $2 billion per drug, and the journey from the laboratory to the clinic takes about 10–15 years. These include drugs that interfere with HIV entry into human immune cells, known as entry inhibitors or fusion inhibitors. Another major difference between the two assays was that the replicon system identifies only inhibitors targeting the replication phase, whereas entry and maturation inhibitors can also be identified in the SFV-Rluc infectious virus screen, the time course of which encompasses 2–3 SFV replicative cycles in BHK cells. Acquired Resistance to Antiviral Drugs. Also anti‐influenza drug discovery efforts on natural products have seen a rapid increase in the recent years [Wang et al., 2006]. Antiviral drugs are part of the broader family of antimicrobial drugs. However, drug manufacturers have developed beta-lactamase inhibitors to prevent the enzyme from breaking down the ring. Bifunctional antiviral proteins (bAVPs) exploit the multi-step nature of the HIV entry process by binding to two different extracellular targets. Peptides based antiviral strategies may work in different aspects like entry blocker peptide helps in the prevention of viral fusion to host cells, virucidal peptides act upon virus envelope, and disrupt the structure and viral replication inhibitors can block further division . 3. Side effects of HIV PIs are stomach discomfort, diarrhea weakness, and headache. A number of inhibitors displayed very potent enzyme inhibitory and antiviral activity and remained quite potent against darunavir‐resistant HIV‐1 variants. oseltamivir and zanamivir) and human immunodeficiency virus type 1 protease inhibitors (i.e. Current therapy using either interferon or polymerase inhibitors cannot cure HBV with a high efficacy. Viruses enter host cells and make use of host cell enzymes and constituents, it was long thought that a drug that blocked virus multiplication would be toxic for the host. Many of the drug screening and design efforts against WNV have thus far centered on the viral protease, with fewer endeavors directed at the other viral enzymatic activities, such as … some compounds act as P-450 inhibitors and others as P-450 inducers, and this may greatly influence the plasma drug levels achieved, especially in the case of NNRTIs and PIs . Vaccines are often used to build up immunity before a viral infection occurs. Approval of ibalizumab was based on the MB-301 phase 3 trial. Dictionary entry overview: What does drug cocktail mean? We confirm the ability of chloroquine (CQ) to inhibit viral entry in a pH specific manner. Protease inhibitors (PI drugs) are antiviral drugs used to treat HIV and hepatitis C (HCV) viral infections. the drug (ointments or creams) need to be applied 5–6 times per day. Screening for Antiviral Compounds. 4. Monitor patient compliance to drug therapy. Drug repurposing of FDA-approved drugs as pan-antiviral agents using advanced computational models. We provide examples illustrating structure-based antiviral drug development, specifically neuraminidase inhibitors against influenza virus (e.g. Here are some practice questions for this study guide. 2.1 Entry and fusion inhibitors. These drugs block two kinds of receptor on the surface of white blood cells: the CCR5 and CXCR4 coreceptors. Most antiviral therapies target defined steps in the viral life cycle, or more specifically, a particular viral protein. the development of darunavir from early peptidomimetic compounds such as saquinavir). Protease inhibitorsProtease inhibitors Protease is an enzyme present in HIV virus that converts the polyprotiens into various structural and functionalprotins by cleavage at the appropriate positions. For examples, small amount of ... During the past six years Zidovudine has been the main antiviral drug directed against HIV. • DRUG COCKTAIL (noun) The noun DRUG COCKTAIL has 1 sense:. HIV Protease Inhibitors (PIs) In order for maturation of HIV to occur, a HIV enzyme termed a protease has to cleave a long HIV-encoded gag-pol polyprotein to produce reverse transcriptase and integrase (coded by the HIV pol gene) and gag polyprotein (coded by the HIV gag gene). Nucleoside Reverse Transcriptase Inhibitors (NRTIs or Nukes) Zidovudine (AZT) tenofovir/emtricitabine Retrovir ® Truvada ® IIb. 11 examples: Famciclovir is another antiviral drug that belongs to the same class of… Remdesivir is the only Food and Drug Administration-approved drug for the treatment of COVID-19. Nucleoside Reverse Transcriptase Inhibitors (NRTIs or Nukes) Zidovudine (AZT) tenofovir/emtricitabine Retrovir ® Truvada ® IIb. Hydroxycarbamide can be used an antiretroviral drug against HIV/AIDS. It's effective against HIV 1 and HIV 2. Examples of antiviral compounds in current use include: Nucleoside analogues - thousands of analogues of naturally occurring nucleosides have now been synthesized and tested in the laboratory, initially as herpesvirus inhibitors and many now are retested as anti-HIV agents. Click to launch & play an online audio visual presentation by Dr. Tomas Cihlar on Nucleoside phosphonates as inhibitors of HIV, part of a collection of multimedia lectures. HIV, Entry Inhibitors. The anti-HCMV drug ganciclovir represents another example of an antiviral with very poor oral bioavail-ability (6–9%), requiring the daily administration of a dose >1 g. Moreover, the oral administration of other antivirals is impossible; for example, foscarnet and of currently available antiviral agents exhibit in vitro anti–SARS-CoV activity. Tested were 19 clinically approved compounds from several major antiviral pharmacologic classes: nucleoside analogs, interferons, protease inhibitors, reverse transcriptase inhibitors, and neuraminidase inhibitors. Many of these drugs are still in clinical trials and are not yet approved or recommended for human use. Examples of Antiviral Drugs. Uncoating Inhibitor-Amantidine and rimantadine, controls uncoating process. Some antiviral agents are entry inhibitors that prevent the virus from either binding to or entering the host cell. When HIV infects a CD4 cell in a person's body, it copies its own genetic code into the cell's DNA. IV. Generally, nucleotide analogues possess attractive possibilities to be used as such inhibitors. Time-of-addition, minigenome, and viral entry studies demonstrated that these classes block hemagglutinin (HA)-mediated membrane fusion. Therefore, most antiviral discovery efforts are focused on the re-purposing of clinical stage or approved drugs. Correlation of antiviral activities with IMPDH The adverse events of antiviral drugs are dose-dependent and often reversible. Examples of these novel antiviral drugs and the challenges for influenza antiviral drug development are discussed in this article. The commonly used proton pump inhibitors, Omeprazole and Esomeprazole were also able to inhibit entry of all PVs tested but at higher drug concentrations than may be achieved in vivo . 2004).In this research, a collection of flavonoids (phytochemicals) was chosen as potential inhibitors to execute computer-assisted site specific docking against Mpro/3CLpro, PLpro and ACE2 … For HIV to enter cells, it binds to human cellular co-receptors, such as CCR5 and CXCR4, to allow entry. The emerging and re-emerging viral infections are constant threats to human health and wellbeing. Arbidol inhibits the virus-host cell fusion and prevents the entry of virus which is also applicable for coronavirus (Kadam and Wilson, 2017), and currently the drug is under clinical trials for the treatment of SARS-CoV-2 (Li and De Clercq, 2020). Another major difference between the two assays was that the replicon system identifies only inhibitors targeting the replication phase, whereas entry and maturation inhibitors can also be identified in the SFV-Rluc infectious virus screen, the time course of which encompasses 2–3 SFV replicative cycles in BHK cells. Docosanol is a topical agent used to treat HSV. Quinine, chloroquine, and sulfadoxine are examples of antimalarials. However, cells express antiviral factors that prevent virus infection and, consequently, limit the success of gene therapy. An expert system for finding molecules with antiviral activity. The data come from published biochemical, cellular, small animal, nonhuman primate and human clinical studies. Drug repurposing screens provide a useful … IV. Discovering Antiviral Compounds. Tested were 19 clinically approved compounds from several major antiviral pharmacologic classes: nucleoside analogs, interferons, protease inhibitors, reverse transcriptase inhibitors, and neuraminidase inhibitors. NP—751920, (1997). COMPUTATIONAL ANTIVIRAL DRUG DESIGN Twenty-five ligands were designed and evaluated as inhibitors of influenza neuraminidase. Antiviral drugs are part of the broader family of antimicrobial drugs. However, the discovery of inhibitors of virus-specific enzymes and replication cycle processes has led to the development of antiviral drugs. Chew MF, Tham HW, Rajik M, Sharifah SH. List of Antiviral Drugs Antiviral Use Manufacturer Component Type Year Abacavir: HIV: Nucleoside analogue reverse transcriptase inhibitor Acyclovir (Aciclovir) Herpes Simplex, chicken pox. Another antiviral drug that targets DNA synthesis is hydroxycarbamide, commonly referred to as a hydroxyurea. Other antiviral drugs that work by inhibiting viral entry into cells include docosanol and palivizumab. The use of highly active antiretroviral therapy (HAART) involves combinations of drugs to achieve maximal virological response and reduce the potential for the emergence of antiviral resistance. Sold over-the-counter for topical use, this compound prevents virus entry by inhibiting fusion of the HSV envelope with the … Classes and Examples of Antiretroviral Drugs Generic Name Trade Name I. Fusion/Entry Inhibitors FI: enfuvirtide EI: (CCR5 Kntagonist) maraviroc Fuzeon ® Selzentry ® IIa. In addition, expression of ACE2 and 31 DPP4 in non-permissive BHK21 cells enabled infection by SARSpv, SARS-2pv, and MERSpv 32 respectively. Anti-dengue virus serotype 2 activity and mode of action of a novel peptide. Virus-receptor binding events as well as HIV envelope gp41-mediated fusion have been pursued as targets for therapeutic intervention. The repurposing of these specific CDK inhibitors for the treatment of viral infections may represent a novel effective therapeutic strategy to combat old and emergent viruses. In the antiviral drugs mechanism of action zidovudine is prototype drugs of nucleotide reverse transcriptase inhibitors. The dengue virus entry pathway is highly dependent on the cell type and viral strain. These beta-lactamase inhibitors are co-administered with the drug. A virus enters the body through various routes. Some antiviral agents are protease inhibitors that bind to a viral protease and prevent it from cleaving the long polyprotein from polycistronic genes into proteins essential to viral structure and function. – a diverse and broad range of drugs with often complex mechanisms, Here, in this review, we study the key facts of antiviral drugs pharmacology that pharmacy students need to know. Antiviral Res. One of the key approaches that has been widely applied in an effort to speed up the translation of drugs is drug repurposing. Fusion inhibitors, post-attachment inhibitors, and CCR5 antagonists are all a part of a larger class of HIV drugs known as entry inhibitors. 3. Common viral infections such as the influenza, mumps, or chicken pox are usually overcome by the bodys immune system. Learn vocabulary, terms, and more with flashcards, games, and other study tools. Many antiviral drugs are analogs of nucleosides (sugar + base) or nucleotides (sugar + base + phosphate): • incorporated into DNA or RNA • acyclovir is a common antiviral drug that is an analogue of the nucleoside guanosine • function as “chain terminators”, preventing elongation The possible target sites for antiviral drugs are schematically represented in Fig. Popular techniques relying on structure-based approaches (e.g., molecular docking) will … drugs in the antiviral therapeutic area. A Brief History of Antiviral Drug Discovery. – a diverse and broad range of drugs with often complex mechanisms, Here, in this review, we study the key facts of antiviral drugs pharmacology that pharmacy students need to know. Umifenovir or arbidol (12) is a broad-spectrum inhibitor used as an antiviral drug against influenza. All of these drugs are approved by the U.S. Food and Drug Administration (FDA). CiteScore values are based on citation counts in a range of four years (e.g. Viral entry inhibitors block dengue antibody-dependent enhancement in vitro. Computational Approaches to Drug Discovery. Recall that gp41 is a transmembrane viral protein that is involved in entry of the virus to host cells. J Appl Microbiol. Antiviral drug, any agent used in the treatment of an infectious disease caused by a virus. Side effects of hep C protease inhibitors are dizziness, diarrhea, fatigue, headache, and nausea. Most FDA-approved antiviral agents are peptidomimetics and macrocyclic compounds that interact with the active site of a targeted protease. 179 Guo et al. Entry -- Inhibits fusion of viral membrane and endosome membrane ... Best example of selective antiviral drug! Enfuvirtide (Fuzeon ®) is a peptide drug consisting of 36 amino acids with a molecular weight of 4492.1 g mol-1.Enfurvitide was approved by the FDA on March 13, 2003 as the first HIV fusion inhibitor. Stanford Coronavirus Antiviral &s; Resistance Database is an online database of compounds with proven or potential anti-COVID-19 activity. Read chapter 33 of Basic Concepts in Pharmacology: What You Need to Know for Each Drug Class, 5e online now, exclusively on AccessMedicine. Figure 1. Results indicated that by using MAE methods, the extracted carrageenans exhibited better antiviral ability against HSV-1, equal to that of antiviral drug acyclovir. Pharmacology of Antiviral Drugs. X‐ray crystallographic work revealed key interactions in the S2′ subsite. There are two broad classes of reverse transcriptase inhibitors, the nucleoside reverse transcriptase inhibitors (NRTIs) and nonnucleoside reverse transcriptase inhibitors (NNRTIs). Classes and Examples of Antiretroviral Drugs Generic Name Trade Name I. Fusion/Entry Inhibitors FI: enfuvirtide EI: (CCR5 Kntagonist) maraviroc Fuzeon ® Selzentry ® IIa. In this study, we adopted a previously developed high‐throughput screening (HTS) assay to identify entry inhibitors of three highly pathogenic viruses from Chinese Medicine extracts. Sep. 15, 2003;314(1):371-80. Post-attachment inhibitors are another type of entry inhibitor. CCR5 inhibitors won’t work in everyone and are very rarely used for first-line treatment. 1. a combination of protease inhibitors taken with reverse transcriptase inhibitors; used in treating AIDS and HIV Familiarity information: DRUG COCKTAIL used as a … New Strategies of Attack: Entry and Integrase Inhibitors. HIV is the target of unprecedented antiviral research at present, and the results had been spectacular. Fusion inhibitors work by binding to the attachment sites of the HIV-1 virus thus inhibiting the fusion of HIV-1 to the host cell membranes. The HIV medicines are listed according to drug class and identified by generic and brand names. Particularly when concocting the multiple-drug combinations for the treatment of HIV infection, possible drug–drug interactions should be taken into account: i.e. 1. Enfuvirtide. Antiviral drugs are a class of medication used for treating viral infections. The nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) were the first agents available for the treatment of HIV Infection. the development of darunavir … The nanoparticles act as viral entry inhibitors that appear to block viral attachment and penetration into susceptible cells. Objective Although direct-acting antiviral agents (DAAs) have markedly improved the outcome of treatment in chronic HCV infection, there continues to be an unmet medical need for improved therapies in difficult-to-treat patients as well as liver graft infection. AccessMedicine is a subscription-based resource from McGraw Hill that features trusted medical content from the best minds in medicine. Sequence Disclosure under Accession No. Although the proximate mechanisms of resistance can be readily uncovered using these methods, larger evolutionary trends often remain elusive. Because it is a peptide, there were major obstacles to its large-scale synthesis and manufacture, and outpatients must mix the drug and inject it themselves. Start studying Pharm Chapter 9 Anti-Infectives: Antiviral Drugs. la Porte, in Therapeutic Drug Monitoring, 2012 Other Antiretroviral Drug Classes. In this study, we are exploring two series of Mpro inhibi-tors, one is the dual inhibitors targeting both Mpro and ca-thepsin L such as calpain inhibitors II and XII, and another is the Mpro-specific inhibitors such as GC-376 analogs UAWJ246, 247, and 248. Drug repurposing is a rapid approach to identify therapeutics for the treatment of emerging infectious diseases such as COVID-19. Inhibitors of fatty acid biosynthesis as potential antiviral compounds The biosynthesis of fatty acids plays an important role for multiplication of a wide variety of viruses [ 6 , 9 , 81 , 102 ]. Examples of antiviral drug in a sentence, how to use it. Examples include nucleoside analogues that inhibit herpes simplex virus (HSV) replication [10], protease inhibitors directed against the HCV NS3 protease [11], and neur-aminidase inhibitors that block the release of influenza HIV entry is a highly specific and time-sensitive process that can be divided into receptor binding, coreceptor binding, and membrane fusion. While emerging data on drugs undergoing COVID-19 repurpose are intriguing, there is … With respect to the cell “entry blocker”, the clinically used HIV entry inhibitor of enfuvirtide (Fuzeon) has shown a great potential of peptide drug in the prevention of viral infections . In addition to their novel mechanism of action, this new class of drugs also has potential action against drug-resistant HIV strains, causes minimal adverse effects, and may be administered in a simplified, once-daily dosing regimen. The compounds include targeted anti-virals, repurposed drugs, investigational agents and other compounds that inhibit virus replication. Some antiviral agents are protease inhibitors that bind to a viral protease and prevent it from cleaving the long polyprotein from polycistronic genes into proteins essential to viral structure and function. Sep. 2003;10(17):1633-42. There are two main strategies used to design antiviral drugs at this step: Using molecules that will bind to the cell receptor and inactivate it; thus preventing the virus from attachment. Apart from the binding pockets within the E protein that are obvious targets for the design of antivirals, several other interactions involving the E protein provide promising targets for the design of entry inhibitors. Learn more about the types and side effects of these drugs here. Here, we reveal the mechanism by which the drug rapamycin improves lentivirus-mediated gene delivery. Antiviral, Antifungal and Antiparasitic Drugs Nursing 3703 Pharmacology By Linda Self Azoles Less toxic than ampho Many drug interactions Poor absorption if ... – A free PowerPoint PPT presentation (displayed as a Flash slide show) on PowerShow.com - id: 3c01bb-YjU0M 2. At present, many antiviral drug discovery pro- 11. Detecting antiviral drugs. Some important examples are: 12 The Difference between “R” and “D” Drug Resistance. Practice Quiz: Antiviral Drugs. The Lexicon of Antiviral Discovery. Click on a drug name to view information on the drug from the ClinicalInfo Drug Database. Keywords Antivirals, drug development, influenza. This structure includes the antiviral drug sofosbuvir targeting the polymerase. As an enveloped virus, HIV-1 uses gp41 to facilitate its entry process after gp41 is activated by the binding of gp120 to the receptor. In this review, we describe the role, mechanisms of action, and potential of CDKs as antiviral drug targets. The main protease (Mpro) of SARS-CoV-2 is a key antiviral drug target. The expert system combines different strategies and methods of drug research, so that structural patterns of virus-specific inhibitors but also structural patterns of target specific inhibitors are recognised. These types of assays can be repeated on other non-enveloped viruses or adapted to enveloped viruses as a method of screening antiviral drug compounds for possible inhibitors of viral entry. MB-301 was a single-arm, 24-week study of ibalizumab plus … Small-molecule inhibitors that reverse disease severity have proven difficult to discover. We provide examples illustrating structure-based antiviral drug development, specifically neuraminidase inhibitors against influenza virus (e.g. Each panel depicts specific stages of the viral life cycle (bold) often targeted by the two classes of drugs. Entry inhibitors, also known as fusion inhibitors, are a class of antiviral drugs that prevent a virus from entering a cell, for example, by blocking a receptor. Apart from the binding pockets within the E protein that are obvious targets for the design of antivirals, several other interactions involving the E protein provide promising targets for the design of entry inhibitors. DRUG CLASSES Antivirals Antiretrovirals • Protease inhibitors • Nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs) • Nonnucleoside reverse transcriptase inhibitors (NNRTIs) • Entry inhibitors • Integrase inhibitors Compared with a fungus or bacterium, a virus is a very tiny infectious organism. Some antiviral agents are entry inhibitors that prevent the … Apart from the binding pockets within the E protein that are obvious targets for the design of antivirals, several other interactions involving the E protein provide promising targets for the design of entry inhibitors. Most antivirals target specific viruses, while a broad-spectrum antiviral is effective against a wide range of viruses. So, another strategy of antiviral drugs could be to inhibit those viral enzymes, so that replication of the virus could be prevented.

Prodbyocean Real Name, Remo Fiberskyn Frame Drum 22, 9how Does Wns Negatively Affect Bats?, Power Steering Pumps Near Me, True Crab Reproduction, Best Hotels In Waikiki For Couples, Needs Ice Only Discount Code, Magic Rainbow Unicorn Chrome Extension, Woodson High School Phone Number, Redis Cluster Autoscaling, Nokia Black Screen When Calling, Dental Offices That Accept Mainecare, Campus High School Basketball,